Efficacy and safety of FangJiHuangQi granule in patients with heart failure: a protocol of randomized, placebo-controlled trial - Summary - MDSpire

Efficacy and safety of FangJiHuangQi granule in patients with heart failure: a protocol of randomized, placebo-controlled trial

  • By

  • Deng Pan

  • Lu Liang

  • Qian Zhao

  • Jianwu Zheng

  • Houyong Zhu

  • Yu Wang

  • Cheng Bao

  • Tielong Chen

  • May 29, 2026

  • 0 min

Share

Objective:

To evaluate the efficacy and safety of FangJiHuangQi Granules (FJHQG) as a complementary therapy in heart failure (HF) patients receiving conventional drug treatment.

Key Findings:
  • FJHQG is derived from a traditional Chinese medicine formula known for its potential benefits in HF.
  • Previous studies indicated that FJHQG may alleviate symptoms and improve cardiac function.
Interpretation:

This study aims to provide clinical evidence on the effectiveness and safety of FJHQG in HF treatment.

Limitations:
  • The study is limited to a specific population and may not be generalizable to all HF patients.
  • Potential biases inherent in randomized controlled trials.
Conclusion:

The trial will assess FJHQG's role in HF management, contributing to understanding its therapeutic mechanisms.

Original Source(s)

Efficacy and safety of FangJiHuangQi granule in patients with heart failure: a protocol of randomized, placebo-controlled trial

  • by Deng Pan, Lu Liang, Qian Zhao, Jianwu Zheng, Houyong Zhu, Yu Wang, Cheng Bao, Tielong Chen

  • May 29, 2026

Related Content

Thoracoscopically assisted resection of left ventricular myxoma: a case report

The inflammatory fingerprint reveals immune cell populations associated with disease activity in cardiac sarcoidosis

Impact of Previous Cardiac Surgery on Outcomes After Tricuspid Valve Transcatheter Edge-to-Edge Repair: Insights from EuroTR